|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 355.5 EUR | +2.16% |
|
+1.86% | -1.11% |
| May. 03 | VIRBAC : Virbac remains an attractive animal healthcare play |  |
| Apr. 17 | VIRBAC : A healthy start to 2024; outlook re-iterated | |
Public release of Virbac Annual Report at 31 December 2023 (ESEF format).
The Group released and filed its 2023 Annual Report with the French “Autorité des marchés financiers”.
The document is also available on the corporate website, at corporate.virbac.com, under “Investors”, “Financial Reports” at the ESEF format and pdf format.
Attachment
| 1st Jan change | Capi. | |
|---|---|---|
| -1.11% | 3.21B | |
| -15.35% | 76.34B | |
| -9.19% | 6.67B | |
| +24.75% | 3.7B | |
| +6.08% | 1.52B | |
| -15.13% | 1.37B | |
| -25.63% | 1.24B | |
| -7.62% | 1.21B | |
| -10.84% | 1.17B | |
| -.--% | 1.05B |
VIRBAC 
